L. Robins, J. Helzer, M. Weissman, H. Orvaschel, E. Gruenberg et al., Lifetime Prevalence of Specific Psychiatric Disorders in Three Sites, Archives of General Psychiatry, vol.41, issue.10, pp.949-958, 1984.
DOI : 10.1001/archpsyc.1984.01790210031005

R. Kessler, K. Mcgonagle, M. Swartz, D. Blazer, and C. Nelson, Sex and depression in the National Comorbidity Survey I: Lifetime prevalence, chronicity and recurrence, Journal of Affective Disorders, vol.29, issue.2-3, pp.85-96, 1993.
DOI : 10.1016/0165-0327(93)90026-G

K. Ritchie, S. Artero, I. Beluche, M. Ancelin, A. Mann et al., Prevalence of DSM--IV psychiatric disorder in the French elderly population, The British Journal of Psychiatry, vol.184, issue.2, pp.147-52, 2004.
DOI : 10.1192/bjp.184.2.147

L. Garcia-segura, I. Azcoitia, and L. Doncarlos, Neuroprotection by estradiol, Progress in Neurobiology, vol.63, issue.1, pp.29-60, 2001.
DOI : 10.1016/S0301-0082(00)00025-3

C. Behl, Oestrogen as a neuroprotective hormone, Nat Rev Neurosci, vol.3, pp.433-475, 2002.

V. Burt and K. Stein, Epidemiology of depression throughout the female life cycle, J Clin Psychiatry, vol.63, pp.9-15, 2002.

S. Kornstein, The evaluation and management of depression in women across the life span

. American-psychiatric-association, Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), 1994.

M. Steiner, T. Pearlstein, L. Cohen, J. Endicott, S. Kornstein et al., Expert Guidelines for the Treatment of Severe PMS, PMDD, and Comorbidities: The Role of SSRIs, Journal of Women's Health, vol.15, issue.1, pp.57-69, 2006.
DOI : 10.1089/jwh.2006.15.57

U. Halbreich, The etiology, biology, and evolving pathology of premenstrual syndromes, Psychoneuroendocrinology, vol.28, issue.3, pp.55-99, 2003.
DOI : 10.1016/S0306-4530(03)00097-0

P. Bebbington, G. Dunn, R. Jenkins, G. Lewis, T. Brugha et al., The influence of age and sex on the prevalence of depressive conditions: report from the National Survey of Psychiatric Morbidity, Psychological Medicine, vol.28, issue.1, pp.9-19, 1998.
DOI : 10.1017/S0033291797006077

U. Halbreich, J. Borenstein, T. Pearlstein, and L. Kahn, The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD), Psychoneuroendocrinology, vol.28, pp.1-23, 2003.
DOI : 10.1016/S0306-4530(03)00098-2

U. Halbreich, Premenstrual dysphoric disorders: a diversified cluster of vulnerability traits to depression, Acta Psychiatrica Scandinavica, vol.23, issue.3, pp.169-176, 1997.
DOI : 10.1016/0165-0327(84)90024-7

D. Rubinow, P. Roy-byrne, M. Hoban, G. Grover, N. Stambler et al., Premenstrual mood changes, Journal of Affective Disorders, vol.10, issue.2, pp.85-90, 1986.
DOI : 10.1016/0165-0327(86)90030-3

B. Harlow, L. Cohen, M. Otto, D. Spiegelman, and D. Cramer, Early life menstrual characteristics and pregnancy experiences among women with and without major depression: the Harvard study of moods and cycles, Journal of Affective Disorders, vol.79, issue.1-3, pp.167-76, 2004.
DOI : 10.1016/S0165-0327(02)00459-7

S. Kimmel, L. Gonsalves, D. Youngs, and G. Gidwani, Fluctuating levels of antidepressants premenstrually, Journal of Psychosomatic Obstetrics & Gynecology, vol.26, issue.33, pp.277-280, 1992.
DOI : 10.3109/01674829209009200

M. Jensvold, K. Reed, D. Jarett, and J. Hamilton, Menstrual Cycle-Related Depressive Symptoms Treated with Variable Antidepressant Dosage, Journal of Women's Health, vol.1, issue.2, pp.109-115, 1992.
DOI : 10.1089/jwh.1992.1.109

P. Schmidt, L. Nieman, G. Grover, K. Muller, G. Merriam et al., Lack of Effect of Induced Menses on Symptoms in Women with Premenstrual Syndrome, New England Journal of Medicine, vol.324, issue.17, pp.1174-1183, 1991.
DOI : 10.1056/NEJM199104253241705

J. Warnock and J. Bundren, Anxiety and mood disorders associated with gonadotropinreleasing hormone agonist therapy, Psychopharmacol Bull, vol.33, pp.311-317, 1997.

C. Brown, F. Ling, R. Andersen, R. Farmer, and K. Arheart, Efficacy of depot leuprolide in premenstrual syndrome: effect of symptom severity and type in a controlled trial, Obstet Gynecol, vol.84, pp.779-86, 1994.

E. Freeman, S. Sondheimer, K. Rickels, and A. J. , Gonadotropin-releasing hormone agonist in treatment of premenstrual symptoms with and without comorbidity of depression: a pilot study, J Clin Psychiatry, vol.54, pp.192-197, 1993.

K. Wyatt, P. Dimmock, K. Ismail, P. Jones, O. Brien et al., The effectiveness of GnRHa with and without 'add-back' therapy in treating premenstrual syndrome: a meta analysis, BJOG: An International Journal of Obstetrics and Gynaecology, vol.64, issue.5, pp.585-93, 2004.
DOI : 10.1136/bmj.323.7316.776

P. Schmidt, L. Nieman, M. Danaceau, L. Adams, and D. Rubinow, Differential Behavioral Effects of Gonadal Steroids in Women with and in Those without Premenstrual Syndrome, New England Journal of Medicine, vol.338, issue.4, pp.209-225, 1998.
DOI : 10.1056/NEJM199801223380401

R. Rupprecht, Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties, Psychoneuroendocrinology, vol.28, issue.2, pp.139-68, 2003.
DOI : 10.1016/S0306-4530(02)00064-1

R. Strous, R. Maayan, and A. Weizman, The relevance of neurosteroids to clinical psychiatry: From the laboratory to the bedside, European Neuropsychopharmacology, vol.16, issue.3, pp.155-69, 2006.
DOI : 10.1016/j.euroneuro.2005.09.005

A. Rapkin, M. Morgan, L. Goldman, D. Brann, D. Simone et al., Progesterone metabolite allopregnanolone in women with premenstrual syndrome, Obstetrics & Gynecology, vol.90, issue.5, pp.709-723, 1997.
DOI : 10.1016/S0029-7844(97)00417-1

P. Monteleone, S. Luisi, A. Tonetti, F. Bernardi, A. Genazzani et al., Allopregnanolone concentrations and premenstrual syndrome, European Journal of Endocrinology, vol.142, issue.3, pp.269-73, 2000.
DOI : 10.1530/eje.0.1420269

M. Wang, L. Seippel, R. Purdy, and T. Backstrom, Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5 alpha-pregnane-3,20-dione and 3 alpha-hydroxy-5 alpha-pregnan- 20-one, J Clin Endocrinol Metab, vol.81, pp.1076-82, 1996.

M. Bicikova, L. Dibbelt, M. Hill, R. Hampl, and L. Starka, Allopregnanolone in Women with Premenstrual Syndrome, Hormone and Metabolic Research, vol.30, issue.04, pp.227-257, 1998.
DOI : 10.1055/s-2007-978871

P. Schmidt, R. Purdy, P. Moore, J. Paul, S. Rubinow et al., Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects, J Clin Endocrinol Metab, vol.79, pp.1256-60, 1994.

S. Girdler, P. Straneva, K. Light, C. Pedersen, and A. Morrow, Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder, Biological Psychiatry, vol.49, issue.9, pp.788-97, 2001.
DOI : 10.1016/S0006-3223(00)01044-1

E. Freeman, C. Frye, K. Rickels, P. Martin, and S. Smith, Allopregnanolone Levels and Symptom Improvement in Severe Premenstrual Syndrome, Journal of Clinical Psychopharmacology, vol.22, issue.5, pp.516-536, 2002.
DOI : 10.1097/00004714-200210000-00013

A. Rapkin, M. Morgan, C. Sogliano, G. Biggio, and A. Concas, Decreased neuroactive steroids induced by combined oral contraceptive pills are not associated with mood changes, Fertility and Sterility, vol.85, issue.5, pp.1371-1379, 2006.
DOI : 10.1016/j.fertnstert.2005.10.031

D. Eser, C. Schule, T. Baghai, E. Romeo, D. Uzunov et al., Neuroactive steroids and affective disorders, Pharmacology Biochemistry and Behavior, vol.84, issue.4, 2006.
DOI : 10.1016/j.pbb.2006.05.020

G. Evans, S. Ross, L. Sellers, E. Purdy, R. Romach et al., 3alpha-reduced neuroactive steroids and their precursors during pregnancy and the postpartum period

P. Murphy, B. Steinberg, S. Hu, F. Allison, and C. , Neuroactive ring A-reduced metabolites of progesterone in human plasma during pregnancy: elevated levels of 5 alphadihydroprogesterone in depressed patients during the latter half of pregnancy, J Clin Endocrinol Metab, vol.86, pp.5981-5988, 2001.

M. Brett and S. Baxendale, Motherhood and memory: a review, Psychoneuroendocrinology, vol.26, issue.4, pp.339-62, 2001.
DOI : 10.1016/S0306-4530(01)00003-8

V. Pop, G. Essed, C. De-geus, M. Van-son, and I. Komproe, Prevalence of post partum depression: or is it post-puerperium depression?, Acta Obstetricia et Gynecologica Scandinavica, vol.72, issue.5, pp.354-362, 1993.
DOI : 10.3109/00016349309021112

A. Josefsson, G. Berg, C. Nordin, and G. Sydsjo, Prevalence of depressive symptoms in late pregnancy and postpartum, Acta Obstetricia et Gynecologica Scandinavica, vol.168, issue.3, pp.251-256, 2001.
DOI : 10.1016/S0165-0327(97)00110-9

J. Evans, J. Heron, H. Francomb, S. Oke, and J. Golding, Cohort study of depressed mood during pregnancy and after childbirth, BMJ, vol.323, issue.7307, pp.257-60, 2001.
DOI : 10.1136/bmj.323.7307.257

R. Kumar and K. Robson, A prospective study of emotional disorders in childbearing women, The British Journal of Psychiatry, vol.144, issue.1
DOI : 10.1192/bjp.144.1.35

J. Watson, S. Elliott, A. Rugg, and D. Brough, Psychiatric disorder in pregnancy and the first postnatal year, The British Journal of Psychiatry, vol.144, issue.5, pp.453-62, 1984.
DOI : 10.1192/bjp.144.5.453

R. Nappi, F. Petraglia, S. Luisi, F. Polatti, C. Farina et al., Serum allopregnanolone in women with postpartum "blues, Obstet Gynecol, vol.97, pp.77-80, 2001.

K. Yonkers, S. Ramin, A. Rush, C. Navarrete, T. Carmody et al., Onset and Persistence of Postpartum Depression in an Inner-City Maternal Health Clinic System, American Journal of Psychiatry, vol.158, issue.11, pp.1856-63, 2001.
DOI : 10.1176/appi.ajp.158.11.1856

P. Hannah, D. Adams, A. Lee, V. Glover, and M. Sandler, Links between early post-partum mood and post-natal depression, The British Journal of Psychiatry, vol.160, issue.6, pp.777-80, 1992.
DOI : 10.1192/bjp.160.6.777

A. Lane, R. Keville, M. Morris, A. Kinsella, M. Turner et al., Postnatal depression and elation among mothers and their partners: prevalence and predictors, The British Journal of Psychiatry, vol.171, issue.6, pp.550-555, 1997.
DOI : 10.1192/bjp.171.6.550

L. Cohen, L. Altshuler, Z. Stowe, and S. Faraone, Reintroduction of Antidepressant Therapy across Pregnancy in Women Who Previously Discontinued Treatment, Psychotherapy and Psychosomatics, vol.73, issue.4, pp.255-263, 2004.
DOI : 10.1159/000077745

L. Altshuler, L. Cohen, M. Moline, D. Kahn, D. Carpenter et al., The Expert Consensus Guideline Series. Treatment of depression in women, Postgrad Med, pp.1-107, 2001.

M. Bloch, P. Schmidt, M. Danaceau, J. Murphy, L. Nieman et al., Effects of Gonadal Steroids in Women With a History of Postpartum Depression, American Journal of Psychiatry, vol.157, issue.6, pp.924-954, 2000.
DOI : 10.1176/appi.ajp.157.6.924

N. Avis, D. Brambilla, S. Mckinlay, and K. Vass, A longitudinal analysis of the association between menopause and depression Results from the Massachusetts women's health study, Annals of Epidemiology, vol.4, issue.3, pp.214-234, 1994.
DOI : 10.1016/1047-2797(94)90099-X

L. Maartens, J. Knottnerus, and V. Pop, Menopausal transition and increased depressive symptomatology, Maturitas, vol.42, issue.3, pp.195-200, 2002.
DOI : 10.1016/S0378-5122(02)00038-5

B. Harlow, L. Wise, M. Otto, C. Soares, and L. Cohen, Depression and Its Influence on Reproductive Endocrine and Menstrual Cycle Markers Associated With Perimenopause, Archives of General Psychiatry, vol.60, issue.1, pp.29-36, 2003.
DOI : 10.1001/archpsyc.60.1.29

L. Dennerstein, J. Guthrie, M. Clark, P. Lehert, and V. Henderson, A population-based study of depressed mood in middle-aged, Australian-born women, Menopause, vol.11, issue.5, pp.563-571, 2004.
DOI : 10.1097/01.GME.0000113844.74462.F6

E. Freeman, M. Sammel, L. Liu, C. Gracia, D. Nelson et al., Hormones and Menopausal Status as Predictors of Depression in Womenin Transition to Menopause, Archives of General Psychiatry, vol.61, issue.1, pp.62-70, 2004.
DOI : 10.1001/archpsyc.61.1.62

E. Freeman, M. Sammel, H. Lin, and D. Nelson, Associations of Hormones and Menopausal Status With Depressed Mood in Women With No History of Depression, Archives of General Psychiatry, vol.63, issue.4, pp.375-82, 2006.
DOI : 10.1001/archpsyc.63.4.375

L. Cohen, C. Soares, A. Vitonis, M. Otto, and B. Harlow, Risk for New Onset of Depression During the Menopausal Transition, Archives of General Psychiatry, vol.63, issue.4, pp.385-90, 2006.
DOI : 10.1001/archpsyc.63.4.385

P. Schmidt, N. Haq, and D. Rubinow, A Longitudinal Evaluation of the Relationship Between Reproductive Status and Mood in Perimenopausal Women, American Journal of Psychiatry, vol.161, issue.12, pp.2238-2282, 2004.
DOI : 10.1176/appi.ajp.161.12.2238

H. Joffe, J. Hall, C. Soares, J. Hennen, C. Reilly et al., Vasomotor symptoms are associated with depression in perimenopausal women seeking primary care, Menopause, vol.9, issue.6, pp.392-400, 2002.
DOI : 10.1097/00042192-200211000-00003

P. Schmidt, L. Nieman, M. Danaceau, M. Tobin, C. Roca et al., Estrogen replacement in perimenopause-related depression: A preliminary report, American Journal of Obstetrics and Gynecology, vol.183, issue.2
DOI : 10.1067/mob.2000.106004

C. Soares, O. Almeida, H. Joffe, and L. Cohen, Efficacy of Estradiol for the Treatment of Depressive Disorders in Perimenopausal Women, Archives of General Psychiatry, vol.58, issue.6, pp.529-534, 2001.
DOI : 10.1001/archpsyc.58.6.529

L. Cohen, C. Soares, J. Poitras, J. Prouty, A. Alexander et al., Short-Term Use of Estradiol for Depression in Perimenopausal and Postmenopausal Women: A Preliminary Report, American Journal of Psychiatry, vol.160, issue.8, pp.1519-1541, 2003.
DOI : 10.1176/appi.ajp.160.8.1519

B. Harlow, D. Cramer, K. Annis, and H. Xu, Association of medically treated depression and age at natural menopause. Does "incessant" ovulation increase risk for early menopause?

R. Daly, M. Danaceau, D. Rubinow, and P. Schmidt, Concordant Restoration of Ovarian Function and Mood in Perimenopausal Depression, American Journal of Psychiatry, vol.160, issue.10, pp.1842-1848, 2003.
DOI : 10.1176/appi.ajp.160.10.1842

D. Kritz-silverstein, V. Muhlen, D. Ganiats, T. Barrett-connor, and E. , Hysterectomy status, estrogen use and quality of life in older women: The Rancho Bernardo study, Quality of Life Research, vol.13, issue.1, pp.55-62, 2004.
DOI : 10.1023/B:QURE.0000015318.00707.53

G. Laughlin, E. Barrett-connor, D. Kritz-silverstein, V. Muhlen, and D. , Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study, J. Clin. Endocrinol. Metab, vol.85, pp.645-651, 2000.

B. Sherwin and M. Gelfand, Sex steroids and affect in the surgical menopause: a double-blind, cross-over study, Psychoneuroendocrinology, vol.10, issue.3, pp.325-335, 1985.
DOI : 10.1016/0306-4530(85)90009-5

M. Taylor, Psychological consequences of surgical menopause, J. Reprod. Med, vol.46, pp.317-324, 2001.

J. Nathorst-boos, V. Schoultz, B. Carlstrom, and K. , Elective ovarian removal and estrogen replacement therapy ??? effects on sexual life, psychological well-being and androgen status, Journal of Psychosomatic Obstetrics & Gynecology, vol.45, issue.4, pp.283-93, 1993.
DOI : 10.1097/00006842-198707000-00009

C. Ballinger, Psychiatric morbidity and the menopause: survey of a gynaecological out- patient clinic, The British Journal of Psychiatry, vol.131, issue.1, pp.83-92, 1977.
DOI : 10.1192/bjp.131.1.83

K. Carlson, B. Miller, F. Fowler, and J. , The Maine Women??s Health Study, Obstetrics & Gynecology, vol.83, issue.4, pp.556-65, 1994.
DOI : 10.1097/00006250-199404000-00012

D. Gath, N. Rose, A. Bond, A. Day, A. Garrod et al., Hysterectomy and psychiatric disorder: are the levels of psychiatric morbidity falling?, Psychological Medicine, vol.20, issue.02, pp.277-83, 1995.
DOI : 10.1192/bjp.140.4.335

M. Ryan, L. Dennerstein, and R. Pepperell, Psychological aspects of hysterectomy. A prospective study, The British Journal of Psychiatry, vol.154, issue.4, pp.516-538, 1989.
DOI : 10.1192/bjp.154.4.516

L. Duffy, D. Greenberg, J. Younger, and M. Ferraro, Iatrogenic Acute Estrogen Deficiency and Psychiatric Syndromes in Breast Cancer Patients, Psychosomatics, vol.40, issue.4, pp.304-342, 1999.
DOI : 10.1016/S0033-3182(99)71223-5

K. Oinonen and D. Mazmanian, To what extent do oral contraceptives influence mood and affect?, Journal of Affective Disorders, vol.70, issue.3, pp.229-269, 2002.
DOI : 10.1016/S0165-0327(01)00356-1

K. Wagner, Major depression and anxiety disorders associated with Norplant, J Clin Psychiatry, vol.57, pp.152-159, 1996.

H. Joffe, L. Cohen, and B. Harlow, Impact of oral contraceptive pill use on premenstrual mood: Predictors of improvement and deterioration, American Journal of Obstetrics and Gynecology, vol.189, issue.6, pp.1523-1553, 2003.
DOI : 10.1016/S0002-9378(03)00927-X

R. Smith, J. Studd, D. Zamblera, and E. Holland, A randomised comparison over 8 months of 100 mug and 200 mug twice weekly doses of transdermal oestradiol in the treatment of severe premenstrual syndrome, BJOG: An International Journal of Obstetrics and Gynaecology, vol.94, issue.6, pp.475-484, 1995.
DOI : 10.1016/S0140-6736(89)90784-8

R. Kroll and A. Rapkin, Treatment of premenstrual disorders, J Reprod Med, vol.51, pp.359-70, 2006.

K. Wyatt, P. Dimmock, O. Brien, and P. , Selective serotonin reuptake inhibitors for premenstrual syndrome, Cochrane Database Syst Rev, p.1396, 2002.

T. Lawrie, A. Herxheimer, and K. Dalton, Oestrogens and progestogens for preventing and treating postnatal depression, Cochrane. Database. Syst. Rev, p.16, 2000.

A. Gregoire, R. Kumar, B. Everitt, A. Henderson, and J. Studd, Transdermal oestrogen for treatment of severe postnatal depression, The Lancet, vol.347, issue.9006, pp.930-933, 1996.
DOI : 10.1016/S0140-6736(96)91414-2

A. Ahokas, J. Kaukoranta, K. Wahlbeck, and M. Aito, Estrogen Deficiency in Severe Postpartum Depression, The Journal of Clinical Psychiatry, vol.62, issue.5, pp.332-338, 2001.
DOI : 10.4088/JCP.v62n0504

C. Soares, J. Poitras, and J. Prouty, Effect of Reproductive Hormones and Selective Estrogen Receptor Modulators on Mood during Menopause, Drugs & Aging, vol.19, issue.10, pp.85-100, 2003.
DOI : 10.2165/00002512-200320020-00001

C. Soares, H. Joffe, L. Cohen, and O. Almeida, Efficacy of 17beta-Estradiol on Depression, The Journal of Clinical Psychiatry, vol.63, issue.5, pp.451-452, 2002.
DOI : 10.4088/JCP.v63n0513a

J. Zweifel, O. Brien, and W. , A meta-analysis of the effect of hormone replacement therapy upon depressed mood, Psychoneuroendocrinology, vol.22, issue.3, pp.189-212, 1997.
DOI : 10.1016/S0306-4530(96)00034-0

G. Robinson, Psychotic and Mood Disorders Associated with the Perimenopausal Period, CNS Drugs, vol.2, issue.3, pp.175-184, 2001.
DOI : 10.2165/00023210-200115030-00002

S. Sherman, Defining the menopausal transition, The American Journal of Medicine, vol.118, issue.12, pp.3-7, 2005.
DOI : 10.1016/j.amjmed.2005.11.002

M. Hlatky, D. Boothroyd, E. Vittinghoff, P. Sharp, and M. Whooley, Quality-of-Life and Depressive Symptoms in Postmenopausal Women After Receiving Hormone Therapy, JAMA, vol.287, issue.5, pp.591-597, 2002.
DOI : 10.1001/jama.287.5.591

A. Maclennan, S. Lester, and V. Moore, Oral estrogen replacement therapy versus placebo for hot flushes: a systematic review, Climacteric, vol.159, issue.1, pp.58-74, 2001.
DOI : 10.1016/0010-7824(77)90112-3

J. Pearce, K. Hawton, and F. Blake, Psychological and sexual symptoms associated with the menopause and the effects of hormone replacement therapy, The British Journal of Psychiatry, vol.167, issue.2, pp.163-73, 1995.
DOI : 10.1192/bjp.167.2.163

V. Burt, L. Altshuler, and N. Rasgon, Depressive Symptoms in the Perimenopause: Prevalence, Assessment, and Guidelines for Treatment, Harvard Review of Psychiatry, vol.6, issue.3, pp.121-153, 1998.
DOI : 10.3109/10673229809000320

P. Schmidt, Mood, depression, and reproductive hormones in the menopausal transition

M. Burnam, K. Wells, B. Leake, and J. Landsverk, Development of a Brief Screening Instrument for Detecting Depressive Disorders, Medical Care, vol.26, issue.8, pp.775-89, 1988.
DOI : 10.1097/00005650-198808000-00004

J. Hays, J. Ockene, R. Brunner, J. Kotchen, J. Manson et al., Effects of Estrogen plus Progestin on Health-Related Quality of Life, New England Journal of Medicine, vol.348, issue.19, pp.1839-54, 2003.
DOI : 10.1056/NEJMoa030311

A. Tuunainen, R. Langer, M. Klauber, and D. Kripke, Short version of the CES-D (Burnam screen) for depression in reference to the structured psychiatric interview, Psychiatry Research, vol.103, issue.2-3, pp.261-70, 2001.
DOI : 10.1016/S0165-1781(01)00278-5

M. Morrison, M. Kallan, T. Have, T. Katz, I. Tweedy et al., Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial, Biological Psychiatry, vol.55, issue.4, pp.406-418, 2004.
DOI : 10.1016/j.biopsych.2003.08.011

S. Resnick and V. Henderson, Hormone Therapy and Risk of Alzheimer Disease, JAMA, vol.288, issue.17, pp.2170-2172, 2002.
DOI : 10.1001/jama.288.17.2170

P. Zandi, M. Carlson, B. Plassman, K. Welsh-bohmer, L. Mayer et al., Hormone Replacement Therapy and Incidence of Alzheimer Disease in Older Women<SUBTITLE>The Cache County Study</SUBTITLE>, JAMA, vol.288, issue.17, pp.2123-2129, 2002.
DOI : 10.1001/jama.288.17.2123

J. Rymer and E. Morris, Extracts from "Clinical Evidence": Menopausal symptoms, BMJ, vol.321, issue.7275, pp.1516-1519, 2000.
DOI : 10.1136/bmj.321.7275.1516

L. Fitzpatrick, C. Pace, and B. Wiita, Comparison of Regimens Containing Oral Micronized Progesterone or Medroxyprogesterone Acetate on Quality of Life in Postmenopausal Women: A Cross-Sectional Survey, Journal of Women's Health & Gender-Based Medicine, vol.9, issue.4, pp.381-388, 2000.
DOI : 10.1089/15246090050020691

L. Andreen, I. Sundstrom-poromaa, M. Bixo, A. Andersson, S. Nyberg et al., Relationship between allopregnanolone and negative mood in postmenopausal women taking sequential hormone replacement therapy with vaginal progesterone, Psychoneuroendocrinology, vol.30, issue.2, pp.212-236, 2005.
DOI : 10.1016/j.psyneuen.2004.07.003

B. Sherwin, The Impact of Different Doses of Estrogen and Progestin on Mood and Sexual Behavior in Postmenopausal Women*, The Journal of Clinical Endocrinology & Metabolism, vol.72, issue.2, pp.336-343, 1991.
DOI : 10.1210/jcem-72-2-336

I. Bjorn, M. Bixo, K. Nojd, S. Nyberg, and T. Backstrom, Negative mood changes during hormone replacement therapy: A comparison between two progestogens, American Journal of Obstetrics and Gynecology, vol.183, issue.6, pp.1419-1445, 2000.
DOI : 10.1067/mob.2000.107781

L. Andreen, M. Bixo, S. Nyberg, I. Sundstrom-poromaa, and T. Backstrom, Progesterone effects during sequential hormone replacement therapy, European Journal of Endocrinology, vol.148, issue.5, pp.571-578, 2003.
DOI : 10.1530/eje.0.1480571

M. Whooley, D. Grady, and J. Cauley, Postmenopausal estrogen therapy and depressive symptoms in older women, Journal of General Internal Medicine, vol.48, issue.8, pp.535-576, 2000.
DOI : 10.1046/j.1525-1497.2000.04029.x

C. Cathcart, S. Jones, C. Pumroy, G. Peters, S. Knox et al., Clinical recognition and management of depression in node negative breast cancer patients treated with tamoxifen, Breast Cancer Research and Treatment, vol.11, issue.2, pp.277-281, 1993.
DOI : 10.1007/BF00665698

R. Day, P. Ganz, and J. Costantino, Tamoxifen and Depression: More Evidence From the National Surgical Adjuvant Breast and Bowel Project's Breast Cancer Prevention (P-1) Randomized Study, JNCI Journal of the National Cancer Institute, vol.93, issue.21
DOI : 10.1093/jnci/93.21.1615

T. Nickelsen, E. Lufkin, B. Riggs, D. Cox, and T. Crook, Raloxifene hydrochloride, a selective estrogen receptor modulator: safety assessment of effects on cognitive function and mood in postmenopausal women, Psychoneuroendocrinology, vol.24, issue.1, pp.115-128, 1999.
DOI : 10.1016/S0306-4530(98)00041-9

R. Strickler, D. Stovall, D. Merritt, W. Shen, M. Wong et al., Raloxifene and Estrogen Effects on Quality of Life in Healthy Postmenopausal Women, Obstetrics & Gynecology, vol.96, issue.3, pp.359-65, 2000.
DOI : 10.1097/00006250-200009000-00008

N. Jarkova, F. Martenyi, D. Masanauskaite, E. Walls, V. Smetnik et al., Mood effect of raloxifene in postmenopausal women, Maturitas, vol.42, issue.1, pp.71-76, 2002.
DOI : 10.1016/S0378-5122(01)00303-6

M. Vessey, D. Fairweather, B. Norman-smith, and J. Buckley, A randomized double-blind controlled trial of the value of stilboestrol therapy in pregnancy: long-term follow-up of mothers and their offspring, BJOG: An International Journal of Obstetrics and Gynaecology, vol.28, issue.11, pp.1007-1017, 1983.
DOI : 10.1016/S0140-6736(78)92237-7

M. Fried-cassorla, T. Scholl, L. Borow, H. Strassman, and E. Bowers, Depression and diethylstilbestrol exposure in women, J Reprod Med, vol.32, pp.847-50, 1987.

R. Pillard, L. Rosen, H. Meyer-bahlburg, J. Weinrich, J. Feldman et al., Psychopathology and social functioning in men prenatally exposed to diethylstilbestrol (DES)., Psychosomatic Medicine, vol.55, issue.6, pp.485-91, 1993.
DOI : 10.1097/00006842-199311000-00003

L. Titus-ernstoff, K. Perez, E. Hatch, R. Troisi, J. Palmer et al., Psychosexual Characteristics of Men and Women Exposed Prenatally to Diethylstilbestrol, Epidemiology, vol.14, issue.2, pp.155-60, 2003.
DOI : 10.1097/01.EDE.0000039059.38824.B2

M. Cole and N. Dendukuri, Risk Factors for Depression Among Elderly Community Subjects: A Systematic Review and Meta-Analysis, American Journal of Psychiatry, vol.160, issue.6, pp.1147-56, 2003.
DOI : 10.1176/appi.ajp.160.6.1147

T. Pearlstein, E. Frank, A. Rivera-tovar, J. Thoft, E. Jacobs et al., Prevalence of axis I and axis II disorders in women with late luteal phase dysphoric disorder, Journal of Affective Disorders, vol.20, issue.2, pp.129-163, 1990.
DOI : 10.1016/0165-0327(90)90126-S

C. Chuong and D. Burgos, Medical history in women with premenstrual syndrome, Journal of Psychosomatic Obstetrics & Gynecology, vol.77, issue.1, pp.21-28, 1995.
DOI : 10.3109/01674829509025653

Z. Stowe and C. Nemeroff, Women at risk for postpartum-onset major depression, American Journal of Obstetrics and Gynecology, vol.173, issue.2, pp.639-684, 1995.
DOI : 10.1016/0002-9378(95)90296-1

M. Bloch, N. Rotenberg, D. Koren, and E. Klein, Risk factors associated with the development of postpartum mood disorders, Journal of Affective Disorders, vol.88, issue.1, pp.9-18, 2005.
DOI : 10.1016/j.jad.2005.04.007

M. Bloch, N. Rotenberg, D. Koren, and E. Klein, Risk factors for early postpartum depressive symptoms, General Hospital Psychiatry, vol.28, issue.1, pp.3-8, 2006.
DOI : 10.1016/j.genhosppsych.2005.08.006

O. Hara, M. Zekoski, E. Philipps, L. Wright, and E. , Controlled prospective study of postpartum mood disorders: Comparison of childbearing and nonchildbearing women., Journal of Abnormal Psychology, vol.99, issue.1, pp.3-15, 1990.
DOI : 10.1037/0021-843X.99.1.3

D. Nielsen-forman, P. Videbech, M. Hedegaard, D. Salvig, J. Secher et al., Postpartum depression: identification of women at risk, BJOG: An International Journal of Obstetrics and Gynaecology, vol.8, issue.10, pp.1210-1217, 2000.
DOI : 10.1016/0022-3999(94)90084-1

S. Chandraiah, H. Richter, and R. Holley, Relationship of reproductive cycle-associated and nonreproductive cycle-associated psychological problems in women, Int J Fertil Womens Med, vol.51, pp.33-40, 2006.

M. Garvey, V. Tuason, A. Lumry, and N. Hoffmann, Occurrence of depression in the postpartum state, Journal of Affective Disorders, vol.5, issue.2, pp.97-101, 1983.
DOI : 10.1016/0165-0327(83)90002-2

J. Webster, J. Linnane, L. Dibley, and M. Pritchard, Improving antenatal recognition of women at risk for postnatal depression, The Australian and New Zealand Journal of Obstetrics and Gynaecology, vol.17, issue.218, pp.409-421, 2000.
DOI : 10.1111/j.1552-6909.1998.tb02589.x

B. Parry and R. Newton, Chronobiological Basis of Female-Specific Mood Disorders, Neuropsychopharmacology, vol.25, issue.5, pp.102-118, 2001.
DOI : 10.1016/S0893-133X(01)00340-2

M. Steiner, Female-Specific Mood Disorders, Clinical Obstetrics and Gynecology, vol.35, issue.3, pp.599-611, 1992.
DOI : 10.1097/00003081-199209000-00020

C. Novaes, O. Almeida, and N. De-melo, Mental health among perimenopausal women attending a menopause clinic: possible association with premenstrual syndrome?, Climacteric, vol.41, issue.4, pp.264-70, 1998.
DOI : 10.1212/WNL.48.6.1517

C. Morse, E. Dudley, J. Guthrie, and L. Dennerstein, Relationships between premenstrual complaints and perimenopausal experiences, Journal of Psychosomatic Obstetrics & Gynecology, vol.16, issue.4, pp.182-91, 1998.
DOI : 10.1080/00049538308255070

D. Stewart and K. Boydell, Psychologic Distress during Menopause: Associations across the Reproductive Life Cycle, The International Journal of Psychiatry in Medicine, vol.48, issue.2, pp.157-62, 1993.
DOI : 10.2190/026V-69M0-C0FF-7V7Y

M. Richards, D. Rubinow, R. Daly, and P. Schmidt, Premenstrual Symptoms and Perimenopausal Depression, American Journal of Psychiatry, vol.163, issue.1, pp.133-140, 2006.
DOI : 10.1176/appi.ajp.163.1.133

URL : http://doi.org/10.1176/appi.ajp.163.1.133

D. Rubinow and P. Schmidt, The Neuroendocrinology of Menstrual Cycle Mood Disorders, Annals of the New York Academy of Sciences, vol.31, issue.1 Stress, pp.648-659, 1995.
DOI : 10.1007/BF02245301

H. Tiemeier, S. Schuit, T. Den-heijer, J. Van-meurs, H. Van-tuijl et al., Estrogen receptor ?? gene polymorphisms and anxiety disorder in an elderly population, Molecular Psychiatry, vol.17, issue.9, pp.806-813, 2005.
DOI : 10.1038/sj.mp.4001697

S. Tsai, Y. Wang, C. Hong, and H. Chiu, Association study of oestrogen receptor ?? gene polymorphism and suicidal behaviours in major depressive disorder, Psychiatric Genetics, vol.13, issue.1, pp.19-22, 2003.
DOI : 10.1097/00041444-200303000-00003

K. Kendler, L. Karkowski, L. Corey, and M. Neale, Longitudinal Population-Based Twin Study of Retrospectively Reported Premenstrual Symptoms and Lifetime Major Depression, American Journal of Psychiatry, vol.155, issue.9, pp.1234-1274, 1998.
DOI : 10.1176/ajp.155.9.1234

M. Steiner, E. Dunn, and L. Born, Hormones and mood: from menarche to menopause and beyond, Journal of Affective Disorders, vol.74, issue.1, pp.67-83, 2003.
DOI : 10.1016/S0165-0327(02)00432-9

D. Rubinow and P. Schmidt, Gonadal steroid regulation of mood: The lessons of premenstrual syndrome???, Frontiers in Neuroendocrinology, vol.27, issue.2, pp.210-216, 2006.
DOI : 10.1016/j.yfrne.2006.02.003

W. Pardridge, T. Moeller, L. Mietus, and W. Oldendorf, Blood-brain barrier transport and brain sequestration of steroid hormones, Am J Physiol, vol.239, pp.96-102, 1980.

L. Speroff, R. Glass, and N. Kase, Clinical gynecologic endocrinology and infertility, pp.59-59, 1994.

F. Facchinetti, A. Genazzani, E. Martignoni, L. Fioroni, G. Nappi et al., Neuroendocrine changes in luteal function in patients with premenstrual syndrome, J Clin Endocrinol Metab, vol.76, pp.1123-1130, 1993.

M. Pike, M. Krailo, B. Henderson, J. Casagrande, and D. Hoel, ???Hormonal??? risk factors, ???breast tissue age??? and the age-incidence of breast cancer, Nature, vol.65, issue.5920, pp.767-770, 1983.
DOI : 10.1038/303767a0

M. Rautalahti, D. Albanes, J. Virtamo, J. Palmgren, J. Haukka et al., Lifetime menstrual activity ? Indicator of breast cancer risk, European Journal of Epidemiology, vol.48, issue.1, pp.17-25, 1993.
DOI : 10.1007/BF00463085

D. Pathak, J. Osuch, and J. He, Breast carcinoma etiology, Cancer, vol.26, issue.S5, pp.1230-1238, 2000.
DOI : 10.1002/(SICI)1097-0142(20000301)88:5+<1230::AID-CNCR9>3.0.CO;2-F

G. Colditz and A. Frazier, Models of breast cancer show that risk is set by events of early life: prevention efforts must shift focus, Cancer. Epidemiol. Biomarkers. Prev, vol.4, pp.567-571, 1995.

T. Nguyen, G. Jones, P. Sambrook, C. White, P. Kelly et al., Effects of estrogen exposure and reproductive factors on bone mineral density and osteoporotic fractures, J

K. Fox, J. Magaziner, R. Sherwin, J. Scott, C. Plato et al., Reproductive correlates of bone mass in elderly women, Journal of Bone and Mineral Research, vol.67, issue.8, pp.901-908, 1993.
DOI : 10.1002/jbmr.5650080802

M. Ancelin and K. Ritchie, Lifelong Endocrine Fluctuations and Related Cognitive Disorders, Current Pharmaceutical Design, vol.11, issue.32, pp.4229-4252, 2005.
DOI : 10.2174/138161205774913228

URL : https://hal.archives-ouvertes.fr/inserm-00243083

E. Frank, P. Rucci, W. Katon, J. Barrett, J. Williams et al., Correlates of remission in primary care patients treated for minor depression, General Hospital Psychiatry, vol.24, issue.1, pp.12-21, 2002.
DOI : 10.1016/S0163-8343(01)00173-6

S. Grigoriadis, S. Kennedy, and R. Bagby, A Comparison of Antidepressant Response in Younger and Older Women, Journal of Clinical Psychopharmacology, vol.23, issue.4, pp.405-412, 2003.
DOI : 10.1097/01.jcp.0000085415.08426.c6

A. Pinto-meza, J. Usall, A. Serrano-blanco, D. Suarez, and J. Haro, Gender differences in response to antidepressant treatment prescribed in primary care. Does menopause make a difference?, Journal of Affective Disorders, vol.93, issue.1-3, pp.53-60, 2006.
DOI : 10.1016/j.jad.2006.02.010

F. Martenyi, M. Dossenbach, K. Mraz, and S. Metcalfe, Gender differences in the efficacy of fluoxetine and maprotiline in depressed patients: a double-blind trial of antidepressants with serotonergic or norepinephrinergic reuptake inhibition profile, European Neuropsychopharmacology, vol.11, issue.3, pp.227-232, 2001.
DOI : 10.1016/S0924-977X(01)00089-X

S. Kornstein, A. Schatzberg, M. Thase, K. Yonkers, J. Mccullough et al., Gender Differences in Treatment Response to Sertraline Versus Imipramine in Chronic Depression, American Journal of Psychiatry, vol.157, issue.9, pp.1445-1452, 2000.
DOI : 10.1176/appi.ajp.157.9.1445

F. Quitkin, J. Stewart, P. Mcgrath, B. Taylor, M. Tisminetzky et al., Are There Differences Between Women???s and Men???s Antidepressant Responses?, American Journal of Psychiatry, vol.159, issue.11
DOI : 10.1176/appi.ajp.159.11.1848

URL : http://doi.org/10.1176/appi.ajp.159.11.1848

P. Cassano, C. Soares, C. Cusin, A. Mascarini, L. Cohen et al., Antidepressant Response and Well-Being in Pre-, Peri- and Postmenopausal Women with Major Depressive Disorder Treated with Fluoxetine, Psychotherapy and Psychosomatics, vol.74, issue.6, pp.362-367, 2005.
DOI : 10.1159/000087783

B. Shapira, G. Oppenheim, J. Zohar, M. Segal, D. Malach et al., Lack of efficacy of estrogen supplementation to imipramine in resistant female depressives, Biological Psychiatry, vol.20, issue.5, pp.576-579, 1985.
DOI : 10.1016/0006-3223(85)90031-9

L. Schneider, G. Small, S. Hamilton, A. Bystritsky, C. Nemeroff et al., Estrogen Replacement and Response to Fluoxetine in a Multicenter Geriatric Depression Trial, American Journal of Geriatric Psychiatry, vol.5, issue.2, pp.97-106, 1997.
DOI : 10.1097/00019442-199721520-00002

L. Schneider, G. Small, and C. Clary, Estrogen Replacement Therapy and Antidepressant Response to Sertraline in Older Depressed Women, The American Journal of Geriatric Psychiatry, vol.9, issue.4, pp.393-399, 2001.
DOI : 10.1097/00019442-200111000-00007

N. Rasgon, L. Altshuler, L. Fairbanks, J. Dunkin, C. Davtyan et al., Estrogen replacement therapy in the treatment of major depressive disorder in perimenopausal women, J. Clin. Psychiatry, vol.63, pp.45-48, 2002.

M. Morgan, I. Cook, A. Rapkin, and A. Leuchter, Estrogen Augmentation of Antidepressants in Perimenopausal Depression, The Journal of Clinical Psychiatry, vol.66, issue.06, pp.774-80, 2005.
DOI : 10.4088/JCP.v66n0617

J. Amsterdam, F. Garcia-espana, J. Fawcett, F. Quitkin, F. Reimherr et al., Fluoxetine efficacy in menopausal women with and without estrogen replacement, Journal of Affective Disorders, vol.55, issue.1, pp.11-17, 1999.
DOI : 10.1016/S0165-0327(98)00203-1

J. Rossouw, G. Anderson, R. Prentice, A. Lacroix, C. Kooperberg et al., Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial, Jama, vol.288, pp.321-354, 2002.

H. Nelson, L. Humphrey, P. Nygren, S. Teutsch, and J. Allan, Postmenopausal Hormone Replacement Therapy, JAMA, vol.288, issue.7, pp.872-81, 2002.
DOI : 10.1001/jama.288.7.872

C. Farquhar, J. Marjoribanks, A. Lethaby, Q. Lamberts, and J. Suckling, Long term hormone therapy for perimenopausal and postmenopausal women, Cochrane Database Syst Rev, p.4143, 2005.

S. Skouby, F. Azzawi, D. Barlow, J. Calaf-alsina-erdogan-ertungealp, A. Gompel et al., Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy, Maturitas, vol.51, issue.1, pp.8-14, 2004.
DOI : 10.1016/j.maturitas.2005.02.019

J. Rymer, R. Wilson, and K. Ballard, Making decisions about hormone replacement therapy, BMJ, vol.326, issue.7384, pp.322-328, 2003.
DOI : 10.1136/bmj.326.7384.322

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1125186

B. Ettinger, E. Barrett-connor, L. Hoq, J. Vader, and R. Dubois, When is it appropriate to prescribe postmenopausal hormone therapy?, Menopause, vol.13, issue.3, pp.404-414, 2006.
DOI : 10.1097/01.gme.0000188735.61994.5b

A. Fournier, F. Berrino, E. Riboli, V. Avenel, and F. Clavel-chapelon, Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort, International Journal of Cancer, vol.158, issue.3, pp.448-54, 2005.
DOI : 10.1002/ijc.20710

URL : https://hal.archives-ouvertes.fr/inserm-00129104

S. Stahl, Sex and Psychopharmacology, Archives of General Psychiatry, vol.58, issue.6, pp.537-545, 2001.
DOI : 10.1001/archpsyc.58.6.537